IOVANCE BIOTHERAPEUTICS, INC. Earnings Per Share (Diluted)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Earnings Per Share (Diluted) of -$0.11 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.11.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.19.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.33.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.36.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for fiscal 2025 was -$1.09.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for fiscal 2024 was -$1.28.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was -$1.89.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was -$2.49.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.11 10-Q · filed 2026-08-06 | -$0.29 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$0.19 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$1.09 10-K · filed 2026-02-24 | |||
| 2025-06-30 | -$0.33 10-Q · filed 2026-08-06 | -$0.69 10-Q · filed 2026-08-06 | -$955.14 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1232.39 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-07 | -$620.34 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$896.60 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$1234.87 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | -$257.65 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$533.06 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$870.77 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.28 10-K · filed 2026-02-24 |
| 2024-09-30 | -$0.28 10-Q · filed 2024-11-07 | -$614.34 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.03 10-Q · filed 2024-11-07 | -$1476.69 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-06-30 | -$0.34 10-Q · filed 2025-08-07 | -$0.76 10-Q · filed 2025-08-07 | -$1213.13 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1672.04 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-03-31 | -$0.42 10-Q · filed 2025-05-08 | -$877.94 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1339.77 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1811.65 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-12-31 | -$454.14 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$916.75 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1390.12 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.89 10-K · filed 2026-02-24 |
| 2023-09-30 | -$0.46 10-Q · filed 2024-11-07 | -$936.80 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.44 10-Q · filed 2024-11-07 | $6.73 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-06-30 | -$0.47 10-Q · filed 2024-08-08 | -$0.98 10-Q · filed 2024-08-08 | $3.72 derived: net income ÷ weighted average shares · filed 2026-04-28 | $16.78 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-03-31 | -$0.50 10-Q · filed 2024-05-09 | $1.65 derived: net income ÷ weighted average shares · filed 2026-04-28 | $9.36 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$28.78 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2022-12-31 | $0.22 derived: net income ÷ weighted average shares · filed 2026-04-28 | $1.31 derived: net income ÷ weighted average shares · filed 2026-04-28 | $5.83 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$2.49 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.63 10-Q · filed 2023-11-07 | -$1.26 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.85 10-Q · filed 2023-11-07 | -$96.55 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2022-06-30 | -$0.63 10-Q · filed 2023-08-08 | -$1.21 10-Q · filed 2023-08-08 | $6.15 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$108.76 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2022-03-31 | -$0.58 10-Q · filed 2023-05-10 | $1.28 derived: net income ÷ weighted average shares · filed 2026-04-28 | $5.80 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$138.90 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2021-12-31 | $0.22 derived: net income ÷ weighted average shares · filed 2026-04-28 | $1.23 derived: net income ÷ weighted average shares · filed 2026-04-28 | $5.45 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$2.23 10-K · filed 2024-02-28 |
| 2021-09-30 | -$0.55 10-Q · filed 2022-11-03 | -$1.08 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.60 10-Q · filed 2022-11-03 | -$4.02 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2021-06-30 | -$0.53 10-Q · filed 2022-08-04 | -$1.04 10-Q · filed 2022-08-04 | -$4.39 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$7.36 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2021-03-31 | -$0.51 10-Q · filed 2022-05-05 | -$977.87 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1377.94 derived: net income ÷ weighted average shares · filed 2023-02-28 | |
| 2020-12-31 | -$465.81 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$865.72 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.88 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$0.40 10-Q · filed 2021-11-04 | -$1.41 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$0.47 10-Q · filed 2021-08-05 | -$1.02 10-Q · filed 2021-08-05 | ||
| 2019-12-31 | -$1.59 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |